Page last updated: 2024-09-04

kw 2189 and du 86

kw 2189 has been researched along with du 86 in 2 studies

Compound Research Comparison

Studies
(kw 2189)
Trials
(kw 2189)
Recent Studies (post-2010)
(kw 2189)
Studies
(du 86)
Trials
(du 86)
Recent Studies (post-2010) (du 86)
10401000

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebisu, H; Fukuda, Y; Furuta, H; Kusama, Y; Oomori, Y; Terashima, S1
Funayama, Y; Isogai, Y; Kanzawa, F; Kuraishi, Y; Lee, YS; Nishio, K; Ogasawara, H; Ohira, T; Saijo, N1

Other Studies

2 other study(ies) available for kw 2189 and du 86

ArticleYear
Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
    Journal of medicinal chemistry, 1999, Apr-22, Volume: 42, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzofurans; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Prodrugs; Pyrroles; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured

1999
Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylic Ester Hydrolases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; DNA; Drug Resistance; Drug Resistance, Multiple; Duocarmycins; Female; Humans; Irinotecan; Lung Neoplasms; Microsomes; Ovarian Neoplasms; Pyrrolidinones; Tumor Cells, Cultured

1995